422 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
in Non-Small Cell Lung Cancer
Executing a Strategic Productivity Initiative to Deliver ~$1.5 Billion in Cost Savings, the Majority of Which … billion in cost savings by the end of 2025, the majority of which will be reinvested to fund innovation and drive growth.
As a part of this initiative
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
Annual election of Directors Majority voting standard for election of Directors Robust Lead Independent Director role Limit on public company board … is binding. If this proposal is approved by the holders of a majority of the outstanding shares of the company, a Certificate of Amendment to our Certificate
8-K
EX-4.1
w5j4fuezed64 0sne3mj
22 Feb 24
Other Events
4:15pm
424B5
ljsbs80 y49
16 Feb 24
Prospectus supplement for primary offering
4:34pm
424B2
b31oa1 k9kfkg6579
13 Feb 24
Prospectus for primary offering
8:00am
SC TO-T/A
EX-99
je11wh
12 Feb 24
Third party tender offer statement (amended)
7:34am
SC TO-T
EX-99
2lvrnesv c7x599pgi
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
1dvb592kyxa ol
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
8l77nh rsahfdba2utbv
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
i649um36g00t jc5skkv
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
z76sf0h07
25 Jan 24
Third party tender offer statement
8:13am
SC TO-C
EX-99.1
ic3xb
26 Dec 23
Information about tender offer
4:22pm
8-K
EX-4.1
4aog9lmrn jke
13 Nov 23
Other Events
4:19pm
424B5
5hqf40r4lbsl
1 Nov 23
Prospectus supplement for primary offering
4:16pm
424B3
62k6c7oj0b3464cf9
30 Oct 23
Prospectus supplement
8:05am